Business HAVN enters psilocybin mushroom supply agreement with Jamaican cannabis producer Green Stripe was one of the first cannabis companies to get established in Jamaica Natalia Buendia CalvilloJune 7, 2022
Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022
Business Optimi enters natural psilocybin supply agreement with Filament Health The mushrooms will be grown and distributed from Optimi's 20,000 square foot EU-GMP facility in Princeton Natalia Buendia CalvilloMay 31, 2022
Business Optimi Health enters psilocybin mushroom supply agreement with Halucenex Life Sciences The shrooms will be supplied to Halucenex in the form of whole, dried mushroom fruiting bodies Natalia Buendia CalvilloMay 27, 2022
Canada Canadian government to grant $3M for psilocybin research studies The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations Natalia Buendia CalvilloMay 5, 2022
Business Field Trip to split into two independent companies Current shareholders of the firm will receive shares of each company Natalia Buendia CalvilloMay 3, 2022
Culture Numinus announces Music as Medicine event series Series of concerts across the U.S. and Canada will explore music’s role in psychedelic-assisted therapy Ryan GarnerMay 3, 2022
Medical and Pharmaceutical Delic Labs granted permission to study psychedelics including LSD, MDMA The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds Ryan GarnerApril 15, 2022
Business Numinus to enter US psychedelics market via $26.2M Novamind acquisition The transaction is expected to close around June Natalia Buendia CalvilloApril 12, 2022
Medical and Pharmaceutical Psilocybin temporarily disrupts stages of the sleep cycle : study But whether or not the disruption helps with the substance's antidepressant properties still needs further research Natalia Buendia CalvilloApril 11, 2022